Yuan-tong Liu

State Key Laboratory Of Oral & Maxillofacial Reconstruction And Regeneration, Key Laboratory Of Oral Biomedicine Ministry Of Education, Hubei Key Laboratory Of Stomatology
Wuhan, 430079, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

Dual-Responsive Epigenetic Inhibitor Nanoprodrug Combined with Oncolytic Virus Synergistically Boost Cancer Immunotherapy by Igniting Gasdermin E-Mediated Pyroptosis.

Dual-Responsive Epigenetic Inhibitor Nanoprodrug Combined with Oncolytic Virus Synergistically Boost Cancer Immunotherapy by Igniting Gasdermin E-Mediated Pyroptosis.

Journal: ACS nano
Published: July 22, 2024

The emerging roles of liquid-liquid phase separation in tumor immunity.

The emerging roles of liquid-liquid phase separation in tumor immunity.

Journal: International immunopharmacology
Published: July 06, 2024

Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy.

Trigger inducible tertiary lymphoid structure formation using covalent organic frameworks for cancer immunotherapy.

Journal: Nature communications
Published: March 19, 2024

Dysregulated Wnt/β-catenin signaling confers resistance to cuproptosis in cancer cells.

Dysregulated Wnt/β-catenin signaling confers resistance to cuproptosis in cancer cells.

Journal: Cell death and differentiation
Published: November 21, 2023

Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma.

Glutamine inhibition combined with CD47 blockade enhances radiotherapy-induced ferroptosis in head and neck squamous cell carcinoma.

Journal: Cancer letters
Published: August 07, 2023

Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma.

Single-cell chemokine receptor profiles delineate the immune contexture of tertiary lymphoid structures in head and neck squamous cell carcinoma.

Journal: Cancer letters
Published: January 25, 2023

Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer.

Targeting PCSK9 reduces cancer cell stemness and enhances antitumor immunity in head and neck cancer.

Journal: iScience
Published: December 12, 2022

Turning cold tumors into hot tumors by improving T-cell infiltration.

Turning cold tumors into hot tumors by improving T-cell infiltration.

Journal: Theranostics
Published: January 19, 2021

CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.

CMTM4 regulates epithelial-mesenchymal transition and PD-L1 expression in head and neck squamous cell carcinoma.

Journal: Molecular carcinogenesis
Published: December 16, 2020
Showing 1-9 of 9

Last Updated: 09/26/2026